Literature DB >> 15167238

Crouzon syndrome: phenotypic signs and symptoms of the postnatally expressed subtype.

Mirjam F Hoefkens1, Christl Vermeij-Keers, J Michiel Vaandrager.   

Abstract

In a retrospective study, the characteristics of a group of patients (n = 9) with a postnatally expressed Crouzon syndrome were described. Although they do not always display the physical signs of craniosynostosis, such patients are highly at risk of developing symptoms secondary to multiple suture synostosis. By reviewing the hospital files, radiographs, and three-dimensional computed tomography scans of these patients, it was possible to describe the pattern of suture obliteration chronologically. Furthermore, certain phenotypic signs and symptoms such as skull shape and development of digital impressions, a bulge at the bregma, and intracranial hypertension were inventoried as well as patients' genotypes. Interestingly, ossification started at the lambdoid sutures in at least four patients and most likely in three additional ones. The coronal sutures were the last to ossify in at least three of the patients. Various skull shapes were encountered. Furthermore, all nine patients developed digital impressions, starting occipitally in eight of them. Seven patients developed a bulge at the bregma, and four of them exhibited intracranial hypertension. The genotype varied in our patients. To recognize patients with postnatal Crouzon syndrome as soon as possible, special attention must be paid to 1) occipital development of digital impressions and/or ossification of sutures, 2) development of a prominent bregma, 3) development of intracranial hypertension, and/or 4) progressive characteristic "crouzonoid" features. Such patients can be considered as representing a subtype of Crouzon syndrome. To prevent or treat intracranial hypertension and/or loss of vision, surgical intervention should be performed at the onset of progressive craniosynostosis between 1 and 2 years of age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167238     DOI: 10.1097/00001665-200403000-00013

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  11 in total

1.  Guideline for Care of Patients With the Diagnoses of Craniosynostosis: Working Group on Craniosynostosis.

Authors:  Irene M J Mathijssen
Journal:  J Craniofac Surg       Date:  2015-09       Impact factor: 1.046

2.  Craniosynostosis.

Authors:  David Johnson; Andrew O M Wilkie
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

Review 3.  Craniosynostosis as a clinical and diagnostic problem: molecular pathology and genetic counseling.

Authors:  Anna Kutkowska-Kaźmierczak; Monika Gos; Ewa Obersztyn
Journal:  J Appl Genet       Date:  2018-02-01       Impact factor: 3.240

4.  Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in "paternal age-effect" syndromes.

Authors:  Anne Goriely; Helen Lord; Jasmine Lim; David Johnson; Tracy Lester; Helen V Firth; Andrew O M Wilkie
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

5.  Quantification of facial skeletal shape variation in fibroblast growth factor receptor-related craniosynostosis syndromes.

Authors:  Yann Heuzé; Neus Martínez-Abadías; Jennifer M Stella; Eric Arnaud; Corinne Collet; Gemma García Fructuoso; Mariana Alamar; Lun-Jou Lo; Simeon A Boyadjiev; Federico Di Rocco; Joan T Richtsmeier
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-27

Review 6.  Brain malformation in syndromic craniosynostoses, a primary disorder of white matter: a review.

Authors:  Charles Raybaud; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2007-09-20       Impact factor: 1.475

Review 7.  A Genetic-Pathophysiological Framework for Craniosynostosis.

Authors:  Stephen R F Twigg; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2015-09-03       Impact factor: 11.025

8.  Phenotypic variability of syndromic craniosynostosis caused by c.833G > T in FGFR2: Clinical and genetic evaluation of eight patients from a five-generation family.

Authors:  Xianda Wei; Guori Huang; Baoheng Gui; Bobo Xie; Shaoke Chen; Xin Fan; Yujun Chen
Journal:  Mol Genet Genomic Med       Date:  2022-03-02       Impact factor: 2.183

Review 9.  Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis.

Authors:  Saïd C Azoury; Sashank Reddy; Vivek Shukla; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2017-11-02       Impact factor: 6.580

10.  Clinical assessment and FGFR2 mutation analysis in a Chinese family with Crouzon syndrome: A case report.

Authors:  Huijun Shi; Jie Yang; Qingmin Guo; Minglian Zhang
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.